AKT1 and neoplasm: Its primary pro-tumor mechanism is the activation of canonical signaling pathways mediated by the ObR-b receptor, such as JAK2/STAT3, PI3K/AKT and MAPK/ERK, and by non-canonical pathways such as PKC, JNK, MAPK/p38 and AMPK [28].